e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Pneumoconioses and interstitial occupational lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Infrequent apoptosis of bronchoalveolar lavage lymphocytes (L-BALs) in pneumoconioses
P. Kopinski, J. Szczeklik, J. Soja, K. Sladek, G. Pinis, A. Szpachcinski, J. Trojan (Bydgoszcz, Krakow, Poland)
Source:
Annual Congress 2004 - Pneumoconioses and interstitial occupational lung disease
Session:
Pneumoconioses and interstitial occupational lung disease
Session type:
Thematic Poster Session
Number:
960
Disease area:
Airway diseases, Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kopinski, J. Szczeklik, J. Soja, K. Sladek, G. Pinis, A. Szpachcinski, J. Trojan (Bydgoszcz, Krakow, Poland). Infrequent apoptosis of bronchoalveolar lavage lymphocytes (L-BALs) in pneumoconioses. Eur Respir J 2004; 24: Suppl. 48, 960
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
The impact of anti-IgE treatment on the airway microbiome in asthma.
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Related content which might interest you:
Lymphocyte and macrophage apoptosis in bronchoalveolar lavage fluid (BALF) of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 749s
Year: 2006
Studies on bronchoalveolar lavage lymphocytes (L-BAL) apoptosis in pulmonary sarcoidosis (PS) and silicosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003
Interferon gamma (IFNgamma) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Altered apoptosis in bronchoalveolar lavage lymphocytes after allergen exposure of atopic asthmatic subjects
Source: Eur Respir J 2006; 28: 513-522
Year: 2006
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Apoptosis of bronchoalveolar lavage lymphocytes in hypersensitivity pneumonitis
Source: Eur Respir J 2003; 21: 225-231
Year: 2003
Bacterial isolation from broncho-alveolar lavage (BAL) or bronchial lavage fluid
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006
Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 198s
Year: 2002
Biochemical markers in bronchoalveolar lavage (BAL)
Source: Eur Respir J 2001; 18: Suppl. 33, 385s
Year: 2001
Activation markers of lymphocytes in bronchoalveolar lavage fluid of different sarcoidosis stages
Source: Eur Respir J 2003; 22: Suppl. 45, 265s
Year: 2003
Experiences with bronchoalveolar lavage (BAL) in children
Source: Eur Respir J 2004; 24: Suppl. 48, 399s
Year: 2004
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Bronchoalveolar lavage and peripheral blood NK cells in idiopathic interstitial pneumonias
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Lipid-laden macrophage index and inflammation in bronchoalveolar lavage fluids in children
Source: Eur Respir J 2001; 18: 790-795
Year: 2001
Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis
Source: Eur Respir J 2003; 21: 144-148
Year: 2003
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept